Clinical Research

maya kowalski case

Non-invasive imaging technique may be key to diagnosing sepsis earlier

The methods enable providers to identify signs of sepsis by assessing blood flow throughout the muscles. 

Thumbnail

Concussions may slow 'background' brain activity in athletes, new imaging shows

New research into post-concussion brain health suggests that the impact of head trauma may be more far-reaching than previously believed. 

Thumbnail

Vaping may affect vascular function as much or more than smoking, MRI study shows

E-cigarettes, or vapes, are largely considered a safer alternative to smoking tobacco cigarettes, but new MRI data suggest they still pose significant risk to users’ health. 

Cardiothoracic surgeons at Emory University Hospital have implanted the BrioVAD System, a new type of ventricular assist device (VAD) from BrioHealth Solutions, for the very first time in the United States.

Surgeons make history with first US implant of new magnetically suspended heart pump

Cardiothoracic surgeons at Emory University Hospital implanted the BrioVAD System, a new type of ventricular assist device from BrioHealth Solutions, for the very first time in the United States. The advanced technology, designed to minimize adverse events and improve quality of life, has been under development since 2008. 

Daniel Judge, MD, director of the cardiovascular genetics program, Medical University of South Carolina, the Edwin W. and Teresa H. Rogers Endowed Chair for Cardiovascular Research, Medical University of South Carolina, presented the results of the late-breaking ATTRibute-CM study for the drug acoramidis used to treat transthyretin amyloidosis at AHA 2024.

ATTR-CM drug acoramidis, now approved by the FDA, linked to positive long-term data

Cardiovascular Business spoke with cardiologist Daniel Judge, MD, about the long-term benefits of acoramidis, a new drug therapy that just received FDA approval to treat transthyretin amyloid cardiomyopathy.

Video of Martha Gulati explaining preventive cardiology advanacements for obese patients. #AHA24 #AHA2024 #CVprev

Martha Gulati highlights 'exciting' progress in preventive cardiology

Martha Gulati, MD, spoke to Cardiovascular Business at AHA Scientific Sessions 2024 about key developments in obesity treatment and CVD prevention.

Deepak Bhatt, MD, MPH, MBA, director of the Mount Sinai Fuster Heart Hospital, explains the research and therapies in development to treat coronary inflammation. In 2023, the FDA cleared the use colchicine and since there has been an explosion of interest in this area. #TCT #TCT24 #TCT2024 #AHA24

Cardiologist examines the latest breakthroughs in coronary inflammation research

Deepak Bhatt, MD, MPH, MBA, spoke to Cardiovascular Business about the growing importance of evaluating coronary inflammation in heart patients. There has been an explosion of interest in this area since the FDA's 2023 clearance of colchicine.

doctor examines patient data on their tablet

Radiologists are more accurate, confident when they know the full story

Providing radiologists with key details about the patient's symptoms can go a long way toward improving the quality of their work.